Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Inflammatory Bowel Diseases

  Free Subscription


2 Am J Gastroenterol
1 BMC Gastroenterol
1 Clin Gastroenterol Hepatol
2 Clin Res Hepatol Gastroenterol
4 Gastroenterol Hepatol
2 Gastroenterology
4 Gut
2 Inflamm Bowel Dis
1 J Clin Gastroenterol
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Gastroenterol

  1. DUNLEAVY K, Fogwe D, Forde G, Ho M, et al
    A Rare Complication: Postoperative Pyoderma Gangrenosum in Segmental Colitis Associated With Diverticulosis.
    Am J Gastroenterol. 2022;117:1734.

  2. CHENG D, Kochar B, Cai T, Ritchie CS, et al
    Comorbidity Influences the Comparative Safety of Biologic Therapy in Older Adults With Inflammatory Bowel Diseases.
    Am J Gastroenterol. 2022;117:1845-1850.
    PubMed         Abstract available

    BMC Gastroenterol

  3. ZAMBRANO-SANCHEZ R, Alvarez-Mena P, Hidalgo D, Liquitay CME, et al
    Quality assessment of Clinical Practice Guidelines (CPG) for the diagnosis and treatment of inflammatory bowel disease using the AGREE II instrument: a systematic review.
    BMC Gastroenterol. 2022;22:447.
    PubMed         Abstract available

    Clin Gastroenterol Hepatol

  4. MAHMOUD R, Savelkoul EHJ, Jharap B, Oldenburg B, et al
    Anti-TNF withdrawal in inflammatory bowel disease with endoscopic healing and the Risk of Relapse- Authors' response.
    Clin Gastroenterol Hepatol. 2022 Nov 3. pii: S1542-3565(22)01017.

    Clin Res Hepatol Gastroenterol

  5. FAVAREL-GARRIGUES M, Cadiot G, Bermejo M, Boulagnon-Rombi C, et al
    Aseptic splenic abscesses as the inaugural manifestation of Crohn's disease.
    Clin Res Hepatol Gastroenterol. 2022;46:101989.

  6. RABILLOUD ML, Bajeux E, Siproudhis L, Hamonic S, et al
    Long-term outcomes and predictors of disabling disease in a population-based cohort of patients with incident Crohn's disease diagnosed between 1994 and 1997.
    Clin Res Hepatol Gastroenterol. 2022;46:101974.
    PubMed         Abstract available

    Gastroenterol Hepatol

  7. HERNANDEZ CAMBA A, Ramos L, Madrid Alvarez MB, Perez-Mendez L, et al
    Psychosocial impact of the COVID-19 pandemic on patients with inflammatory bowel disease in Spain. A post lockdown reflection.
    Gastroenterol Hepatol. 2022;45:668-676.
    PubMed         Abstract available

  8. DEL HOYO J, Millan M, Garrido-Marin A, Nos P, et al
    Changes in the management of IBD patients since the onset of COVID-19 pandemic. A path toward the implementation of telemedicine in Spain?
    Gastroenterol Hepatol. 2022;45:697-705.
    PubMed         Abstract available

  9. LADRON ABIA P, Minguez Sabater A, Saez Gonzalez E, Beltran Niclos B, et al
    Rescue therapy with oral cyclosporine after use of ustekinumab in ulcerative colitis resistant to multiple treatments.
    Gastroenterol Hepatol. 2022;45:735-736.

  10. JULIAO-BANOS F, Osorio L, Carvajal J, Mosquera-Klinger G, et al
    Clinical characteristics and treatment of perianal fistulising Crohn's disease in Colombia: Results of a multicentric registry.
    Gastroenterol Hepatol. 2022;45:690-696.
    PubMed         Abstract available


  11. WELZ L, Aden K
    Fibrosis and Inflammation in Inflammatory Bowel Disease-More Than 2 Sides of the Same Coin?
    Gastroenterology. 2022 Oct 29. pii: S0016-5085(22)01246.

  12. KUFTINEC GN, Lim JE, Yarur AJ
    A Rare but Devastating Dermatologic Manifestation of Ulcerative Colitis.
    Gastroenterology. 2022 Nov 3. pii: S0016-5085(22)01253.


  13. ZOLLER H, Wolf M, Blumenstein I, Primas C, et al
    Hypophosphataemia following ferric derisomaltose and ferric carboxymaltose in patients with iron deficiency anaemia due to inflammatory bowel disease (PHOSPHARE-IBD): a randomised clinical trial.
    Gut. 2022 Sep 9. pii: gutjnl-2022-327897. doi: 10.1136/gutjnl-2022-327897.
    PubMed         Abstract available

  14. ADOLPH TE, Zhang J
    Diet fuelling inflammatory bowel diseases: preclinical and clinical concepts.
    Gut. 2022;71:2574-2586.
    PubMed         Abstract available

  15. SALAS A
    What good can neutrophils do in UC?
    Gut. 2022;71:2375-2376.

  16. LETT MJ, Mehta H, Keogh A, Jaeger T, et al
    Stimulatory MAIT cell antigens reach the circulation and are efficiently metabolised and presented by human liver cells.
    Gut. 2022;71:2526-2538.
    PubMed         Abstract available

    Inflamm Bowel Dis

  17. LICHTENSTEIN GR, Bressler B, Francisconi C, Vermeire S, et al
    Assessment of Safety and Efficacy of Tofacitinib, Stratified by Age, in Patients from the Ulcerative Colitis Clinical Program.
    Inflamm Bowel Dis. 2022 Nov 7. pii: 6808367. doi: 10.1093.
    PubMed         Abstract available

  18. SHIMOYAMA T, Yamamoto T, Yoshiyama S, Nishikawa R, et al
    Leucine-Rich Alpha-2 Glycoprotein Is a Reliable Serum Biomarker for Evaluating Clinical and Endoscopic Disease Activity in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2022 Nov 5. pii: 6804445. doi: 10.1093.
    PubMed         Abstract available

    J Clin Gastroenterol

  19. GUERRERO VINSARD D, Wakefield D, Karagozian R, Farraye FA, et al
    Herpes Zoster in Hospitalized Patients With Inflammatory Bowel Disease: National Analysis of Disease Presentation and Age Distribution.
    J Clin Gastroenterol. 2022 Nov 9. pii: 00004836-990000000-00090.
    PubMed         Abstract available

    PLoS One

  20. SAHIN M, Erdogan KE, Tekingunduz E
    Correlation between the tissue ghrelin presence, disease activity and laboratory parameters in ulcerative colitis patients; immunohistochemical study.
    PLoS One. 2022;17:e0276065.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.